Equine Oral Sugar Test: What to Record With Your Horse's Result
Learn which fasting, syrup, sampling and laboratory details belong with an equine oral sugar test result, and why changed protocols complicate rechecks.
What an oral sugar test result needs beside the number
An equine oral sugar test (OST) measures the insulin response to an oral carbohydrate challenge. To make the result useful at the next visit, keep the test date, fasting preparation, syrup product and dose, actual blood-draw times, laboratory, assay, units and interpretation threshold together. An insulin number without those details can be hard to compare with a later result. Cornell's Animal Health Diagnostic Center describes the OST as more sensitive than a single baseline insulin sample for detecting equine metabolic syndrome (EMS). Cornell AHDC testing guidance.
The clinical question is whether the horse has an excessive insulin response, a feature of insulin dysregulation (ID) associated with laminitis risk. A normal resting insulin concentration does not exclude ID, and a cresty neck or obesity alone does not diagnose EMS. Some affected horses are lean. The veterinarian combines the history, examination and appropriately interpreted testing rather than diagnosing from appearance or a number copied from another horse's report. Merck Veterinary Manual.
The OST does not measure tissue insulin sensitivity in isolation. Digestion, absorption, gut hormone effects, insulin secretion and insulin clearance all contribute to the response. Lindåse and colleagues explicitly distinguish an oral challenge response from a direct measure of insulin resistance. This is why a change in an OST result needs clinical interpretation rather than an automatic conclusion that tissue insulin sensitivity improved or worsened by the same amount. Lindåse et al. (2016).
One test name, several published protocols
The following comparison separates laboratory guidance, a clinical manual, consensus recommendations and research methods. It does not combine them into a new testing protocol. In particular, the serial sampling used in a study is not automatically required for every clinical appointment. Record the method your veterinary team actually chooses, including any deliberate departure from an earlier test.
| Source and setting | Preparation described | Syrup dose described | Samples described |
|---|---|---|---|
| Cornell AHDC laboratory guidance | Overnight fast | 0.15 mL/kg Karo Light; 0.45 mL/kg high-dose option | Baseline optional; 60 and/or 90 minutes |
| EEG recommendations, 2024 | 3–6 hour fast | 0.15 mL/kg corn syrup; 0.45 mL/kg high-dose option | 60 and/or 90 minutes; insulin and glucose |
| Merck Veterinary Manual, August 2025 | 3–6 hour fast | 0.15–0.45 mL/kg corn syrup | 60 or 90 minutes |
| Lindåse et al., 2016 research protocol | 12-hour overnight feed withdrawal; water available | 0.2 mL/kg Scandinavian glucose syrup | Before dosing, then 30, 60, 90, 120, 150 and 180 minutes |
| Karikoski et al., 2021 online / 2022 issue, research protocol | Hay slice no later than 22:00; morning start 06:00–09:00 | 0.45 mL/kg Karo Light | 0, 60, 90 and 120 minutes |
The practical fasting issue is the difference between the instruction and what happened. Cornell specifies overnight fasting. EEG and Merck describe a 3–6 hour fast; Merck explains a limited-hay overnight arrangement as one way to achieve it. Do not infer the actual fasting interval merely from the time hay was offered, because eating takes time. Record the instruction, the last known feed access and any unexpected grazing or treats. Ask the veterinarian how to handle uncertainty instead of silently treating the visit as an exact repeat.
Syrup identity matters as well as volume. In 2016, Lindåse's modified Scandinavian OST delivered 216 mg/kg of saccharides, compared with an estimated 150 mg/kg of digestible sugars for the US protocol discussed in that paper: a 44% higher total sugar dose. That comparison reflects both product and administered dose, not simply 44% greater sugar density in a bottle. The authors reported that Karo's composition was withheld at the time, limiting their ability to reproduce an identical challenge. It does not establish the composition of every product sold today. Lindåse et al. methods and discussion.
A result sheet should therefore identify the product actually used, the dose rate selected by the veterinarian and the administered volume. A record saying only 'corn syrup test' loses information. A product substitution or a change from the lower-dose to the higher-dose protocol should remain visible in the record, so a later reviewer does not mistake the altered challenge for a change in the horse alone.
Interpret the threshold with its dose and assay
There is no single insulin cutoff that can safely be detached from the test method. Merck's August 2025 review gives an OST concentration of at least 45 mcIU/mL at 60 or 90 minutes as consistent with ID within its described protocol. Karikoski's research classified ID using at least 20 µIU/mL at baseline or at least 40 µIU/mL at a post-dose sampling point, with a particular assay and high-dose challenge. Those are source-specific interpretation rules, not alternative numbers for an owner to choose between. Merck diagnostic section; Karikoski et al. classification criteria.
The 2024 EEG recommendations give a lower-dose threshold above 45 µIU/mL and discuss the 0.45 mL/kg OST separately, with thresholds above 65 µIU/mL for RIA or above 63 µIU/mL for the Immulite 2000 xpi assay. These stated inequalities and methods belong with the protocol. The recommendations also caution that range boundaries are not absolute and that values close to a boundary need interpretation. Ask the laboratory which dose, sample time and assay its interpretation assumes, and retain that answer with the result. If a report's comment and an online table appear to disagree, seek clarification from the veterinarian and laboratory. EEG diagnostic recommendations.
Assay differences can create another source of disagreement. Lindåse's paper discusses earlier comparisons of the Coat-A-Count radioimmunoassay and Mercodia equine ELISA: agreement was good below approximately 150 µU/mL and poor at higher concentrations. The paper did not newly perform that head-to-head assay comparison. Its cited conversion factor of 10 from RIA mU/L to ELISA ng/L belongs to those methods; it is not a universal conversion that makes results from any two laboratories interchangeable. Lindåse et al. assay discussion.
Keep the units exactly as reported. Common microunit-per-milliliter notations may use µ or u, and reports can use different unit systems as well as different assays. Ask the laboratory to explain equivalence rather than changing the original report. Even after units are reconciled, the method-specific reference interval and clinical interpretation still matter. When switching laboratories, attach both original reports and ask whether the new measurement can be compared directly with the old one.
Sample handling belongs in the clinical record too. Cornell accepts plain red-top serum tubes or lavender-top EDTA plasma tubes for these submissions and warns against serum-tube additives, including separator gels and clot activators, because of potential assay interference. Its processing guidance calls for transferring separated serum or plasma into a suitable shipping vial, generally freezing unless shipping the same day, and using overnight shipment with cold packs so samples arrive chilled. These are Cornell's requirements; another laboratory's instructions must be checked separately. Cornell sample collection and processing guidance.
Recording the collection tube and handling history helps the veterinarian investigate a questionable result. It cannot prove that an assay was unaffected or that the cold chain remained intact. Research papers may use tubes or storage conditions that differ from a clinical submission laboratory's rules. Copying a study's specimen method into a field appointment without laboratory agreement would defeat the purpose of documenting the protocol.
Why the actual sampling minute matters
Karikoski and colleagues performed 171 high-dose OSTs in 29 Finnhorses over a year. The maximum measured insulin occurred at 60 minutes in 61 tests, at 90 minutes in 46 and at 120 minutes in 57. One test had its maximum at baseline. In six tests, peak timing could not be determined because values were all below detection or all post-dose values exceeded the assay's measuring range. The counts describe repeated tests in a small cohort, not 171 independent horses. Karikoski et al. results.
Among tests peaking at 60 minutes, eight would have changed from ID to non-ID if the horse had been sampled only at either of the other two post-dose time points. The corresponding counts were seven among tests peaking at 90 minutes and four among those peaking at 120 minutes. These are conditional missed-case counts grouped by peak timing; they do not assign a false-negative rate to each possible one-sample schedule. They also cannot establish a general sensitivity estimate for every dose, assay or horse population.
This study supports recording timing and discussing the sample plan with the veterinarian. It does not establish a universal requirement for a 120-minute draw. The investigators used the 0.45 mL/kg challenge, one breed at a northern latitude, changing management conditions and an assay whose reportable range ended at 300 µIU/mL. Its sampling observations should not be transferred unchanged to a lower-dose protocol or a different laboratory.
Write the administration time and every actual draw time rather than rounding an imperfect visit back to the intended schedule. Label whether a sample was taken before dosing or afterward. If administration was incomplete, a draw was delayed or one planned sample could not be obtained, record the deviation and ask the veterinarian how it affects interpretation. A contemporaneous note is more useful than reconstructing the sequence from memory after the report arrives.
EMS and PPID answer different testing questions
EMS and pituitary pars intermedia dysfunction (PPID) can occur together, but an OST and an ACTH test answer different questions. The OST evaluates insulin regulation after an oral challenge. ACTH-based testing helps investigate PPID. Cornell notes that EMS is seen primarily in horses younger than 15 years and PPID usually in older horses; age patterns are clinical context rather than absolute diagnostic boundaries. An older horse may need evaluation for both conditions. Cornell EMS overview.
Merck reports concurrent EMS and PPID in approximately 30% of cases in middle-aged and older horses and recommends considering both problems where appropriate. An OST does not diagnose a pituitary lesion, and an ACTH result cannot substitute for the insulin challenge record. Keep the tests clearly named on a combined laboratory submission. A normal result from one investigation should not be treated as automatic exclusion of the condition addressed by the other. Merck discussion of concurrent PPID.
A record to keep with each test report
Use this record alongside the laboratory report and the clinic's instructions. It is a documentation aid, not a validated scoring system or a self-testing form. Ask the clinic to complete the technical fields you cannot observe. Unknown details should be marked unknown rather than guessed from a previous visit. Keep one record per date and preserve the original report when a later laboratory or clinician takes over care.
| Field | Record for this visit | Why keep it |
|---|---|---|
| Horse, date and team | Horse identity; date; attending veterinarian; clinic contact | Keeps the protocol attached to the correct patient and visit |
| Clinical context | Reason for testing; diet and exercise context; hoof history; current illness and medications | Helps the veterinarian interpret context rather than the number alone |
| Test type | OST, resting insulin, postprandial monitoring or another named test | Prevents comparison of different testing questions as though they were the same |
| Fasting | Written instruction; last known feed access; feed type; any deviation | Distinguishes prescribed preparation from what occurred |
| Product and dose | Syrup name; veterinarian-selected mL/kg; volume administered; administration time | Identifies product changes and lower-dose versus higher-dose challenges |
| Samples | Baseline obtained or omitted; actual time of every draw; elapsed post-dose minutes | Preserves the timing associated with each individual result |
| Specimens | Tube type; processing and storage notes from the clinic; receiving laboratory | Allows review against that laboratory’s submission requirements |
| Assay and report | Laboratory and accession number; insulin assay; result for each sample; exact units | Retains the measurement method and original values |
| Interpretation | Laboratory threshold and comments; veterinarian’s assessment; person providing it | Separates a reported number from the clinical conclusion |
| Next step | Agreed management or follow-up plan; responsible person; recheck timing | Keeps responsibility and the follow-up question explicit |
For an owner, the useful contribution is often logistical: share the fasting instructions with everyone who feeds the horse, keep the appointment notes, and obtain the full report instead of a text message containing one value. Ask who will record administration and draw times. For the veterinary team, linking each sample label to the correct timestamp and test type makes the submission easier to interpret and the next visit easier to compare.
Before comparing two visits, place the records side by side. Check test type, preparation, syrup, dose, sampling times, assay and units first. If one or more changed, flag the difference for the clinician. A lower later number may still be useful, but it does not by itself establish how much the horse improved. A missing field is a reason to qualify the comparison, not a reason to discard all of the clinical information.
Changing results and the question for a recheck
In Karikoski's cohort, 12 of 29 horses changed ID classification during the year. The study did not find significant seasonal variation in its OST insulin measures. That finding argues against assuming an automatic autumn rise in every OST result, but it does not prove that season or management never matters in other horses. The authors identified the single breed and nonconstant feeding and exercise conditions as limitations. Repeated testing may help in suspicious cases; its timing remains a veterinary decision. Karikoski et al. conclusions and limitations.
A follow-up visit should begin with the question being asked: is this a repeat diagnostic challenge, or is the veterinarian checking the response to the horse's current diet? Merck recommends a postprandial insulin measurement about two hours after feeding for monitoring a previously diagnosed case. Its monitoring bands belong to that setting. They should not be pasted onto a timed syrup challenge, a fasting baseline or a sample taken at an unspecified time. Merck follow-up guidance.
Ask which earlier result will serve as the comparison, which protocol details should be kept consistent and what any planned change means for interpretation. Also ask what action depends on the result and who will communicate it. Keeping the original methods and the clinical decision together makes the next number useful without turning an owner’s record into an independent diagnosis.
Sources
Cornell University College of Veterinary Medicine, AHDC. Equine Metabolic Syndrome (EMS) Testing. Laboratory-specific preparation, dose, sampling and specimen instructions.
Merck Veterinary Manual. Equine Metabolic Syndrome (Insulin Dysregulation). Full review August 2025. Clinical interpretation, diagnostic limitations, PPID overlap and follow-up context.
Lindåse S, Nostell K, Bröjer J. A modified oral sugar test for evaluation of insulin and glucose dynamics in horses. Acta Veterinaria Scandinavica. 2016;58(Suppl 1):64. Modified-syrup research methods and discussion of assay comparability.
Karikoski NP, Box JR, Mykkänen AK, Kotiranta VV, Raekallio MR. Variation in insulin response to oral sugar test in a cohort of horses throughout the year and evaluation of risk factors for insulin dysregulation. Equine Veterinary Journal. 2022;54(5):905–913; published online 2021. Repeated high-dose OSTs in Finnhorses; sampling-time observations and study limitations.
Equine Endocrinology Group. Recommendations for the Diagnosis and Management of Equine Metabolic Syndrome (EMS) and Insulin Dysregulation. 2024; distributed as Final Oct. 2024 recommendations. Consensus recommendations, including dose- and assay-dependent OST interpretation.
